Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32722
Procedure to Use Quantitative Bone-Specific SPECT/CT in North Karelia Central Hospital

Authors: L. Korpinen, P. Taskinen, P. Rautio


This study aimed to describe procedures that we developed to use in the quantitative, bone-specific SPECT/CT at our hospital. Our procedures included the following questions for choosing imaging protocols, which were based on a clinical doctor's referral: (1) Is she/he a cancer patient or not? (2) Are there any indications of inflammatory rheumatoid arthritis? We performed about 1,106 skeletal scintigraphies over two years. About 394 patients were studied with quantitative bone-specific single-photon emission computed tomography/computerized tomography (SPECT/CT) (i.e., about 36% of all bone scintigraphies). Approximately 64% of the patients were studied using the conventional Anterior-Posterior/Posterior-Anterior imaging. Our procedure has improved efficiency and decreased cycle times.

Keywords: Skeletal scintigraphy, SPECT/CT, imaging.

Digital Object Identifier (DOI):

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1113


[1] K. Torsten, “Skeletal SPECT/CT: a review,” Clin Transl Imaging, vol. 2, pp. 505–517, December. 2014.
[2] M. Tuncel E. Lay Ergun, and T. M. Caglar, “Clinical impact of SPECT-CT on bone scintigraphy in oncology: pattern approach,” J BUON, vol. 21, pp. 1296–1306, September-October 2016.
[3] T. Van den Wyngaert, K. Strobel, W. U. Kampen, T. Kuwert, W. van der Bruggen, H. K. Mohan, G. Gnanasegaran, R. Delgado-Bolton, W. A. Weber, M. Beheshti, W. Langsteger, F. Giammarile, F. M. Mottaghy, F. Paycha, corresponding author and on behalf of the EANM Bone & Joint Committee and the Oncology Committee, The EANM practice guidelines for bone scintigraphy, Eur J Nucl Med Mol Imaging, 43, pp. 1723–1738, June. 2016.
[4] I. Kuji, T. Yamane, A. Seto, Y. Yasumizu, S. Shirotake and M. Oyama,“Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer,” European Journal of Hybrid Imaging, vol. 1, p. 2, October2017.
[5] STUK, Use of radiation in health care
[6] O. Rager, R. Nkoulou, N. Exquis, V. Garibotto, C. Tabouret-Viaud, H. Zaidi, G. Amzalag, S. Anne Lee-Felker, T. Zilli, and O. Ratib, “Whole-Body SPECT/CT versus Planar Bone Scan with Targeted SPECT/CT for Metastatic Workup,” BioMed Research International, vol. Article ID 7039406, 8 pages, July 2017.